Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Targeting defective pulmonary innate immunity - A new therapeutic option?

Belchamber KBR, Donnelly LE.

Pharmacol Ther. 2020 Feb 12:107500. doi: 10.1016/j.pharmthera.2020.107500. [Epub ahead of print] Review.

PMID:
32061706
2.

Defective bacterial phagocytosis is associated with dysfunctional mitochondria in COPD macrophages.

Belchamber KBR, Singh R, Batista CM, Whyte MK, Dockrell DH, Kilty I, Robinson MJ, Wedzicha JA, Barnes PJ, Donnelly LE; COPD-MAP consortium.

Eur Respir J. 2019 Oct 10;54(4). pii: 1802244. doi: 10.1183/13993003.02244-2018. Print 2019 Oct.

PMID:
31320451
3.

Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease.

Finney LJ, Belchamber KBR, Fenwick PS, Kemp SV, Edwards MR, Mallia P, Donaldson G, Johnston SL, Donnelly LE, Wedzicha JA.

Am J Respir Crit Care Med. 2019 Jun 15;199(12):1496-1507. doi: 10.1164/rccm.201806-1095OC.

4.

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function.

Belchamber KB, Thomas CM, Dunne AE, Barnes PJ, Donnelly LE.

Int J Chron Obstruct Pulmon Dis. 2018 Sep 17;13:2883-2897. doi: 10.2147/COPD.S169337. eCollection 2018.

5.

Reduced Clearance of Fungal Spores by Chronic Obstructive Pulmonary Disease GM-CSF- and M-CSF-derived Macrophages.

Wrench C, Belchamber KBR, Bercusson A, Shah A, Barnes PJ, Armstrong-James D, Donnelly LE.

Am J Respir Cell Mol Biol. 2018 Feb;58(2):271-273. doi: 10.1165/rcmb.2017-0351LE. No abstract available.

6.

Correcting the "Wandering" Neutrophil with Statins. A Novel Antiaging Strategy?

Belchamber KBR, Donnelly LE.

Am J Respir Crit Care Med. 2017 Nov 15;196(10):1243-1244. doi: 10.1164/rccm.201707-1410ED. No abstract available.

7.

Macrophage Dysfunction in Respiratory Disease.

Belchamber KBR, Donnelly LE.

Results Probl Cell Differ. 2017;62:299-313. doi: 10.1007/978-3-319-54090-0_12. Review.

PMID:
28455714
8.

Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD.

Bewley MA, Belchamber KB, Chana KK, Budd RC, Donaldson G, Wedzicha JA, Brightling CE, Kilty I, Donnelly LE, Barnes PJ, Singh D, Whyte MK, Dockrell DH; COPDMAP.

PLoS One. 2016 Sep 28;11(9):e0163139. doi: 10.1371/journal.pone.0163139. eCollection 2016.

9.

Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD.

Costa C, Traves SL, Tudhope SJ, Fenwick PS, Belchamber KB, Russell RE, Barnes PJ, Donnelly LE.

Eur Respir J. 2016 Apr;47(4):1093-102.

Supplemental Content

Loading ...
Support Center